Gastroduodenal motility

Area of Science:

• Gastroenterology
• Neurogastroenterology
• Digestive Physiology

Background:

• Upper gastrointestinal motility, governed by neuromuscular functions, drives digestion and influences satiety and dyspepsia.
• Neuroendocrine factors play a crucial role in regulating these functions.

Purpose of the Study:

• To review neuroendocrine control of upper gastrointestinal motility.
• To discuss noninvasive techniques for evaluating gastroduodenal motility.
• To examine the pathophysiology and treatment of gastroparesis.

Main Methods:

• Review of current literature on neuroendocrine factors, motility assessment techniques, and gastroparesis.
• Discussion of noninvasive imaging modalities like MRI for evaluating gastric function.
• Analysis of emerging therapeutic strategies for gastroparesis.

Main Results:

• Nutrient sensing in the duodenum triggers feedback inhibition of gastric emptying via cholecystokinin (CCK) and serotonin (5-HT).
• Tumor necrosis factor-alpha (TNF-α) mediates gastric inhibition through the dorsal vagal complex.
• Magnetic resonance imaging (MRI) offers a noninvasive method for assessing gastric accommodation and contractions, comparing favorably with the barostat.
• Gastroparesis is linked to end-stage liver disease, with portal hypertension contributing to gastric dysfunction.
• Clonidine, sildenafil, and intrapyloric botulinum toxin show potential in treating gastroparesis.

Conclusions:

• Future drug development may target specific receptors (5-HT3, CCK, TNF-α).
• Spatiotemporal mapping using advanced imaging (ultrasound, CT, MRI) can enhance diagnostic capabilities.
• Improving gastric accommodation may be more beneficial for gastroparesis symptom relief than solely enhancing gastric emptying.